Call for Balancing the Risks and Benefits of Immunotherapeutic Agents for Lymphoma during the COVID-19 Pandemic
- Author:
Chan Mi LEE
1
;
Wan Beom PARK
Author Information
- Publication Type:Editorial
- From:Infection and Chemotherapy 2024;56(3):406-408
- CountryRepublic of Korea
- Language:English
